Understanding the binding interaction between methotrexate and human alpha-2-macroglobulin: Multi-spectroscopic and...

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• Methotrexate (MTX) is a crucial drug for treating various cancers and autoimmune diseases.
• A significant portion of circulating MTX binds to plasma proteins, influencing its distribution and efficacy.
• Alpha-2-macroglobulin (α2M) is a major plasma proteinase inhibitor with diverse biological roles.

Purpose of the Study:

• To investigate the binding interaction between methotrexate (MTX) and alpha-2-macroglobulin (α2M).
• To characterize the functional and structural consequences of MTX binding to α2M.
• To elucidate the biophysical mechanisms underlying the MTX-α2M interaction.

Main Methods:

• Protein functional activity assays to assess antiproteolytic potential.
• UV-visible absorption and intrinsic fluorescence spectroscopy to study binding.
• Far UV Circular Dichroism (CD) spectroscopy for structural analysis.
• Isothermal Titration Calorimetry (ITC) for thermodynamic characterization.
• Molecular docking and Molecular Dynamics (MD) simulations for interaction details.

Main Results:

• MTX binding caused a 53% decrease in α2M's antiproteolytic activity.
• Spectroscopic studies indicated hyperchromicity and static quenching, suggesting drug binding.
• CD spectra revealed minor alterations in α2M's secondary structure.
• ITC confirmed a spontaneous and exothermic binding process.
• Molecular docking identified key amino acid residues involved in the interaction.
• MD simulations demonstrated the formation of a stable MTX-α2M complex.

Conclusions:

• Methotrexate directly binds to alpha-2-macroglobulin, altering its structure and function.
• The interaction is thermodynamically favorable, spontaneous, and exothermic.
• Understanding this binding is crucial for optimizing MTX therapy and predicting its pharmacokinetic behavior.